[
  {
    "ts": null,
    "headline": "BTAL: Unconvincing Long-Short ETF",
    "summary": "The AGF U.S. Market Neutral Anti-Beta Fund (BTAL) is long in 200 low-beta stocks and short in 200 high-beta stocks. Read the full analysis here.",
    "url": "https://finnhub.io/api/news?id=e9c8229720fc2528f411f8ef642b75e06ea92222f9541b86139f83b1f40c39e4",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761330698,
      "headline": "BTAL: Unconvincing Long-Short ETF",
      "id": 137203845,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1154731469/image_1154731469.jpg?io=getty-c-w1536",
      "related": "ABT",
      "source": "SeekingAlpha",
      "summary": "The AGF U.S. Market Neutral Anti-Beta Fund (BTAL) is long in 200 low-beta stocks and short in 200 high-beta stocks. Read the full analysis here.",
      "url": "https://finnhub.io/api/news?id=e9c8229720fc2528f411f8ef642b75e06ea92222f9541b86139f83b1f40c39e4"
    }
  },
  {
    "ts": null,
    "headline": "Abbott Laboratories (ABT): Exploring Valuation After a Recent Share Price Pullback",
    "summary": "Abbott Laboratories (ABT) stock has drifted slightly lower this month, with shares showing a 7% drop over the past month. However, year to date, the company has delivered an 11% gain, reflecting underlying strength in its business. See our latest analysis for Abbott Laboratories. After a steady climb earlier this year, Abbott Laboratories’ share price momentum has cooled off a bit, with the recent 1-month share price return of -7% standing out against an otherwise solid 11% year-to-date gain...",
    "url": "https://finnhub.io/api/news?id=bb447acc7023f23ddbdb7e2438caabba7d946267bec1ac82a5e72c9198028f73",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761307983,
      "headline": "Abbott Laboratories (ABT): Exploring Valuation After a Recent Share Price Pullback",
      "id": 137216270,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "ABT",
      "source": "Yahoo",
      "summary": "Abbott Laboratories (ABT) stock has drifted slightly lower this month, with shares showing a 7% drop over the past month. However, year to date, the company has delivered an 11% gain, reflecting underlying strength in its business. See our latest analysis for Abbott Laboratories. After a steady climb earlier this year, Abbott Laboratories’ share price momentum has cooled off a bit, with the recent 1-month share price return of -7% standing out against an otherwise solid 11% year-to-date gain...",
      "url": "https://finnhub.io/api/news?id=bb447acc7023f23ddbdb7e2438caabba7d946267bec1ac82a5e72c9198028f73"
    }
  }
]